secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001641172-25-009667
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis Q1 revenue $7.5M (+9% YoY); recurring up 29%; operating loss widens to $5.9M
--------------------------------------------------------------------------------

- Revenue $7.5M (+9% YoY); system revenue $2.0M, recurring revenue $5.5M (+29% driven by Map-iT catheters).
- Operating loss ($5.9M) vs ($4.7M) prior year; net loss ($5.8M) vs ($4.5M). Adjusted operating loss ($2.7M).
- Cash $10.7M, no debt; free cash flow negative ($1.8M), improved from ($2.3M) YoY.
- Reiterates FY 2025 double-digit revenue growth; expects recurring revenue to scale to $7M in Q4.
- First GenesisX order received; initial MAGiC commercialization in Europe; six active regulatory reviews.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000164117225009667/0001641172-25-009667-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000164117225009667/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009667

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer